PMID- 35723643 OWN - NLM STAT- MEDLINE DCOM- 20230215 LR - 20230215 IS - 1122-0643 (Print) IS - 1122-0643 (Linking) VI - 93 IP - 1 DP - 2022 Jun 20 TI - Pulmonary rehabilitation: A novel adjunct in management of obstructive sleep apnea. LID - 10.4081/monaldi.2022.2260 [doi] AB - Pulmonary rehabilitation (PR) is being used in the routine management of patients of obstructive sleep apnea (OSA) at some centers. However, the studies documenting benefits of PR in OSA lack standardization in terms of outcome measures. A study was hence planned to determine the efficacy of PR on exercise capacity, health related quality of life (HRQOL), day time sleepiness and sleep-quality of life (QOL) in patients of OSA. As a part of comprehensive therapy, patients diagnosed with OSA are managed with continuous positive airway pressure (CPAP), 8 weeks thrice weekly outpatient hospital-based PR and medical treatment at the Pulmonary Medicine Department, Government Medical College and Hospital, Chandigarh. However, some patients refuse for PR because of time constraints and travel issues. Patients with newly diagnosed OSA without co-existing respiratory disease, who agreed for the CPAP, PR and medical management were enrolled in group A. The patients who refused for PR but were ready for CPAP and medical management were enrolled in Group B; 30 patients were taken in each group. Exercise capacity, HRQOL, day time sleepiness and sleep-QOL were determined at baseline and at 8-weeks follow-up by 6-minute walk distance (6MWD), St. George's Respiratory Questionnaire (SGRQ), Epworth Sleepiness Scale (ESS) and Functional Outcomes of Sleep Questionnaire (FOSQ) and compared amongst the two groups. Four patients from group A were excluded as they did not complete PR; 26 patients from group A and 30 patients from group B were finally analyzed. At baseline, both groups were matched with respect to age, gender, apnea-hypopnea index (AHI), body mass index (BMI), FEV1%predicted, 6MWD, SGRQ, ESS and FOSQ. At follow up at 8 weeks, BMI, 6MWD, SGRQ, ESS and FOSQ improved significantly from baseline in group A (p<0.001). FEV1%predicted also improved but non significantly. In group B, FEV1%predicted, BMI, 6MWD, SGRQ, ESS and FOSQ score did not improve significantly from baseline. Mean improvement from baseline in BMI, 6MWD, SGRQ, ESS and FOSQ was significantly more in group A than group B (p<0.001, p<0.001, p=0.041, p<0.001 and p<0.001, respectively). PR, being beneficial, should be incorporated in standard management of OSA. FAU - Agarwal, Prakhar AU - Agarwal P AD - Department of Pulmonary Medicine Critical Care and Sleep Medicine, All India Institute of Medical Sciences, Bhopal. praksag21@gmail.com. FAU - Garg, Kranti AU - Garg K AD - Department of Pulmonary Medicine, Government Medical College, Patiala. drkrantigarg@yahoo.com. FAU - Saini, Varinder AU - Saini V AD - Department of Pulmonary Medicine, Government Medical College and Hospital, Sector 32, Chandigarh. varindersaini62@gmail.com. FAU - Singh, Isha AU - Singh I AD - Business Administration in Hospital Management, Panjab University, Chandigarh. singhishasingh25@gmail.com. LA - eng PT - Journal Article DEP - 20220620 PL - Italy TA - Monaldi Arch Chest Dis JT - Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace JID - 9307314 SB - IM MH - Humans MH - *Quality of Life MH - Treatment Outcome MH - Sleepiness MH - *Sleep Apnea, Obstructive/therapy/diagnosis MH - Outcome Assessment, Health Care EDAT- 2022/06/21 06:00 MHDA- 2023/02/16 06:00 CRDT- 2022/06/20 10:33 PHST- 2022/03/09 00:00 [received] PHST- 2022/06/10 00:00 [accepted] PHST- 2022/06/21 06:00 [pubmed] PHST- 2023/02/16 06:00 [medline] PHST- 2022/06/20 10:33 [entrez] AID - 10.4081/monaldi.2022.2260 [doi] PST - epublish SO - Monaldi Arch Chest Dis. 2022 Jun 20;93(1). doi: 10.4081/monaldi.2022.2260.